494 related articles for article (PubMed ID: 32915172)
1. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)
Klimek L; Pfaar O; Worm M; Eiwegger T; Hagemann J; Ollert M; Untersmayr E; Hoffmann-Sommergruber K; Vultaggio A; Agache I; Bavbek S; Bossios A; Casper I; Chan S; Chatzipetrou A; Vogelberg C; Firinu D; Kauppi P; Kolios A; Kothari A; Matucci A; Palomares O; Szépfalusi Z; Pohl W; Hötzenecker W; Rosenkranz AR; Bergmann KC; Bieber T; Buhl R; Buters J; Darsow U; Keil T; Kleine-Tebbe J; Lau S; Maurer M; Merk H; Mösges R; Saloga J; Staubach P; Jappe U; Rabe KF; Rabe U; Vogelmeier C; Biedermann T; Jung K; Schlenter W; Ring J; Chaker A; Wehrmann W; Becker S; Freudelsperger L; Mülleneisen N; Nemat K; Czech W; Wrede H; Brehler R; Fuchs T; Tomazic PV; Aberer W; Fink-Wagner AH; Horak F; Wöhrl S; Niederberger-Leppin V; Pali-Schöll I; Pohl W; Roller-Wirnsberger R; Spranger O; Valenta R; Akdis M; Matricardi PM; Spertini F; Khaltaev N; Michel JP; Nicod L; Schmid-Grendelmeier P; Idzko M; Hamelmann E; Jakob T; Werfel T; Wagenmann M; Taube C; Jensen-Jarolim E; Korn S; Hentges F; Schwarze J; O Mahony L; Knol EF; Del Giacco S; Chivato Pérez T; Bousquet J; Bedbrook A; Zuberbier T; Akdis C; Jutel M
Allergol Select; 2020; 4():53-68. PubMed ID: 32915172
[TBL] [Abstract][Full Text] [Related]
2. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).
Pfaar O; Bachert C; Bufe A; Buhl R; Ebner C; Eng P; Friedrichs F; Fuchs T; Hamelmann E; Hartwig-Bade D; Hering T; Huttegger I; Jung K; Klimek L; Kopp MV; Merk H; Rabe U; Saloga J; Schmid-Grendelmeier P; Schuster A; Schwerk N; Sitter H; Umpfenbach U; Wedi B; Wöhrl S; Worm M; Kleine-Tebbe J; Kaul S; Schwalfenberg A
Allergo J Int; 2014; 23(8):282-319. PubMed ID: 26120539
[TBL] [Abstract][Full Text] [Related]
3. "Delabeling" by direct provocation testing in children and adolescents with a suspected history of a delayed reaction to β-lactam antibiotics: Consensus paper of Gesellschaft für pädiatrische Allergologie und Umweltmedizin (GPAU), Deutsche Gesellschaft für Allergologie und klinische Immunologie (DGAKI), and Ärzteverband deutscher Allergologen (ÄDA).
Neustädter I; Blatt S; Wurpts G; Dickel H; Walter C; Aberer W; Bode S; Buhl T; Gernert S; Harner S; Heine G; Kerzel S; Köhler M; Lange L; List J; Merk HF; Nüßlein T; Ott H; Sattler F; Schuster A; Straube H; Wedi B; Zuberbier T; Brockow K
Allergol Select; 2024; 8():206-211. PubMed ID: 38835749
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) - A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA).
Pfaar O; Klimek L; Hamelmann E; Kleine-Tebbe J; Taube C; Wagenmann M; Werfel T; Brehler R; Novak N; Mülleneisen N; Becker S; Worm M
Allergol Select; 2021; 5():140-147. PubMed ID: 33842829
[TBL] [Abstract][Full Text] [Related]
5. [Fusion der Arbeitsgemeinschaft Allergologie der Deutschen Dermatologischen Gesellschaft (DDG) mit der Sektion Dermatologie der Deutschen Gesellschaft für Allergologie und Klinische Immunologie (DGAKI) im Mai 2023 vollzogen].
Wedi B; Treudler R
J Dtsch Dermatol Ges; 2023 Nov; 21(11):1437. PubMed ID: 37946649
[No Abstract] [Full Text] [Related]
6. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement.
Vultaggio A; Agache I; Akdis CA; Akdis M; Bavbek S; Bossios A; Bousquet J; Boyman O; Chaker AM; Chan S; Chatzipetrou A; Feleszko W; Firinu D; Jutel M; Kauppi P; Klimek L; Kolios A; Kothari A; Kowalski ML; Matucci A; Palomares O; Pfaar O; Rogala B; Untersmayr E; Eiwegger T
Allergy; 2020 Nov; 75(11):2764-2774. PubMed ID: 32500526
[TBL] [Abstract][Full Text] [Related]
7. Abridged version of the AWMF guideline for the medical clinical diagnostics of indoor mould exposure: S2K Guideline of the German Society of Hygiene, Environmental Medicine and Preventive Medicine (GHUP) in collaboration with the German Association of Allergists (AeDA), the German Society of Dermatology (DDG), the German Society for Allergology and Clinical Immunology (DGAKI), the German Society for Occupational and Environmental Medicine (DGAUM), the German Society for Hospital Hygiene (DGKH), the German Society for Pneumology and Respiratory Medicine (DGP), the German Mycological Society (DMykG), the Society for Pediatric Allergology and Environmental Medicine (GPA), the German Federal Association of Pediatric Pneumology (BAPP), and the Austrian Society for Medical Mycology (ÖGMM).
Wiesmüller GA; Heinzow B; Aurbach U; Bergmann KC; Bufe A; Buzina W; Cornely OA; Engelhart S; Fischer G; Gabrio T; Heinz W; Herr CEW; Kleine-Tebbe J; Klimek L; Köberle M; Lichtnecker H; Lob-Corzilius T; Merget R; Mülleneisen N; Nowak D; Rabe U; Raulf M; Seidl HP; Steiß JO; Szewszyk R; Thomas P; Valtanen K; Hurraß J
Allergo J Int; 2017; 26(5):168-193. PubMed ID: 28804700
[TBL] [Abstract][Full Text] [Related]
8. Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA Group
Klimek L; Pfaar O; Worm M; Bergmann KC; Bieber T; Buhl R; Buters J; Darsow U; Keil T; Kleine-Tebbe J; Lau S; Maurer M; Merk H; Mösges R; Saloga J; Staubach P; Stute P; Rabe K; Rabe U; Vogelmeier C; Biedermann T; Jung K; Schlenter W; Ring J; Chaker A; Wehrmann W; Becker S; Mülleneisen N; Nemat K; Czech W; Wrede H; Brehler R; Fuchs T; Tomazic PV; Aberer W; Fink-Wagner A; Horak F; Wöhrl S; Niederberger-Leppin V; Pali-Schöll I; Pohl W; Roller-Wirnsberger R; Spranger O; Valenta R; Akdis M; Akdis C; Hoffmann-Sommergruber K; Jutel M; Matricardi P; Spertin F; Khaltaev N; Michel JP; Nicod L; Schmid-Grendelmeier P; Hamelmann E; Jakob T; Werfel T; Wagenmann M; Taube C; Gerstlauer M; Vogelberg C; Bousquet J; Zuberbier T
Allergol Select; 2020; 4():44-52. PubMed ID: 32568272
[TBL] [Abstract][Full Text] [Related]
9. [Specific immunotherapy. Hyposensitization with allergens].
Wedi B; Kapp A
Hautarzt; 2004 Apr; 55(4):399-407; quiz 408-9. PubMed ID: 15146875
[TBL] [Abstract][Full Text] [Related]
10. Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI.
Klimek L; Bergmann KC; Brehler R; Pfützner W; Zuberbier T; Hartmann K; Jakob T; Novak N; Ring J; Merk H; Hamelmann E; Ankermann T; Schmidt S; Untersmayr E; Hötzenecker W; Jensen-Jarolim E; Brockow K; Mahler V; Worm M
Allergo J Int; 2021; 30(3):79-95. PubMed ID: 33898162
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2: recommendations for treatment in intensive care medicine.
Köstenberger M; Hasibeder W; Dankl D; Germann R; Hörmann C; Joannidis M; Markstaller K; Müller-Muttonen SO; Neuwersch-Sommeregger S; Schaden E; Staudinger T; Ullrich R; Valentin A; Likar R
Wien Klin Wochenschr; 2020 Nov; 132(21-22):664-670. PubMed ID: 32948888
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper.
Pfaar O; Klimek L; Jutel M; Akdis CA; Bousquet J; Breiteneder H; Chinthrajah S; Diamant Z; Eiwegger T; Fokkens WJ; Fritsch HW; Nadeau KC; O'Hehir RE; O'Mahony L; Rief W; Sampath V; Schedlowski M; Torres MJ; Traidl-Hoffmann C; Wang Y; Zhang L; Bonini M; Brehler R; Brough HA; Chivato T; Del Giacco SR; Dramburg S; Gawlik R; Gelincik A; Hoffmann-Sommergruber K; Hox V; Knol EF; Lauerma A; Matricardi PM; Mortz CG; Ollert M; Palomares O; Riggioni C; Schwarze J; Skypala I; Untersmayr E; Walusiak-Skorupa J; Ansotegui IJ; Bachert C; Bedbrook A; Bosnic-Anticevich S; Brussino L; Canonica GW; Cardona V; Carreiro-Martins P; Cruz AA; Czarlewski W; Fonseca JA; Gotua M; Haahtela T; Ivancevich JC; Kuna P; Kvedariene V; Larenas-Linnemann DE; Abdul Latiff AH; Mäkelä M; Morais-Almeida M; Mullol J; Naclerio R; Ohta K; Okamoto Y; Onorato GL; Papadopoulos NG; Patella V; Regateiro FS; Samoliński B; Suppli Ulrik C; Toppila-Salmi S; Valiulis A; Ventura MT; Yorgancioglu A; Zuberbier T; Agache I
Allergy; 2021 Mar; 76(3):648-676. PubMed ID: 32531110
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals-EAACI recommendations.
Jutel M; Torres MJ; Palomares O; Akdis CA; Eiwegger T; Untersmayr E; Barber D; Zemelka-Wiacek M; Kosowska A; Palmer E; Vieths S; Mahler V; Canonica WG; Nadeau K; Shamji MH; Agache I
Allergy; 2022 Aug; 77(8):2313-2336. PubMed ID: 35147230
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostics and expert opinion in the occupational disease No. 4101 silicosis (including coal worker's pneumoconiosis). Guideline (S2; AWMF) of the Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin and the Deutsche Gesellschaft für Arbeitsmedizin und Umweltmedizin].
Baur X; Heger M; Köhler D; Kranig A; Letzel S; Schultze-Werninghaus G; Tannapfel A; Teschler H; Voshaar T; Bohle MR; Erlinghagen N; Hering KG; Hofmann-Preiss K; Kraus T; Merget R; Michaely G; Neumann V; Nowak D; Ozbek I; Piasecki HJ; Staubach-Wicke N; ; ; ;
Pneumologie; 2008 Nov; 62(11):659-84. PubMed ID: 18988146
[No Abstract] [Full Text] [Related]
15. [National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients].
Wagenlehner FM; Schmiemann G; Hoyme U; Fünfstück R; Hummers-Pradier E; Kaase M; Kniehl E; Selbach I; Sester U; Vahlensieck W; Watermann D; Naber KG
Urologe A; 2011 Feb; 50(2):153-69. PubMed ID: 21312083
[TBL] [Abstract][Full Text] [Related]
16. [Care of patients under mechanical ventilation at home and in nursing home conditions. Position paper of the German Medical Associations of Pneumology and Ventilatory Support ("Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e. V." and "Arbeitsgemeinschaft für Heimbeatmung und Respiratorentwöhnung e. V.")].
Randerath W; Lorenz J; Windisch W; Criée CP; Karg O; Köhler D; Laier-Gröneveld G; Pfeifer M; Schönhofer B; Teschler H; Vogelmeier C;
Pneumologie; 2008 May; 62(5):305-8. PubMed ID: 18461538
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.
Agache I; Beltran J; Akdis C; Akdis M; Canelo-Aybar C; Canonica GW; Casale T; Chivato T; Corren J; Del Giacco S; Eiwegger T; Firinu D; Gern JE; Hamelmann E; Hanania N; Mäkelä M; Hernández-Martín I; Nair P; O'Mahony L; Papadopoulos NG; Papi A; Park HS; Pérez de Llano L; Posso M; Rocha C; Quirce S; Sastre J; Shamji M; Song Y; Steiner C; Schwarze J; Alonso-Coello P; Palomares O; Jutel M
Allergy; 2020 May; 75(5):1023-1042. PubMed ID: 32034960
[TBL] [Abstract][Full Text] [Related]
18. Biologics for atopic diseases: Indication, side effect management, and new developments.
Jappe U; Beckert H; Bergmann KC; Gülsen A; Klimek L; Philipp S; Pickert J; Rauber-Ellinghaus MM; Renz H; Taube C; Treudler R; Wagenmann M; Werfel T; Worm M; Zuberbier T
Allergol Select; 2021; 5():1-25. PubMed ID: 33426426
[TBL] [Abstract][Full Text] [Related]
19. Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (ÖGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM).
Brockow K; Przybilla B; Aberer W; Bircher AJ; Brehler R; Dickel H; Fuchs T; Jakob T; Lange L; Pfützner W; Mockenhaupt M; Ott H; Pfaar O; Ring J; Sachs B; Sitter H; Trautmann A; Treudler R; Wedi B; Worm M; Wurpts G; Zuberbier T; Merk HF
Allergo J Int; 2015; 24(3):94-105. PubMed ID: 26120552
[TBL] [Abstract][Full Text] [Related]
20. [Guideline (S2k, AWMF) of the Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin and the Deutsche Gesellschaft für Arbeitsmedizin und Umweltmedizin "Diagnostics and Expert Opinion in the Occupational Disease No. 4101 Silicosis (Including Coal Worker's Pneumoconiosis)"].
Baur X; Heger M; Bohle RM; Hering KG; Hofmann-Preiß K; Nowak D; Tannapfel A; Teschler H; Voshaar T; Kraus T;
Pneumologie; 2016 Dec; 70(12):782-812. PubMed ID: 27931056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
